M. de Ladurantaye

发表

RNA and DNA Integrity Remain Stable in Frozen Tissue After Long-Term Storage at Cryogenic Temperatures: A Report from the Ontario Tumour Bank.

John M S Bartlett, O. Dokun, Rachel Kelly, 2019, Biopreservation and biobanking.

BMP-2 signaling in ovarian cancer and its association with poor prognosis

C. Le Page, A. Mes-Masson, D. Provencher, 2009, Journal of ovarian research.

Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

Ali Bashashati, Richard A. Moore, Gavin Ha, 2017, Nature Genetics.

Prostaglandin E2 Regulates the Level and Stability of Cyclooxygenase-2 mRNA through Activation of p38 Mitogen-activated Protein Kinase in Interleukin-1β-treated Human Synovial Fibroblasts*

A. Mancini, J. D. Di Battista, Wissam H. Faour, 2001, The Journal of Biological Chemistry.

Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma

A. Mes-Masson, D. Provencher, V. Barrès, 2015, BioMed research international.

Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.

C. Le Page, A. Mes-Masson, D. Huntsman, 2013, Biopreservation and biobanking.

Detection of Human Papillomavirus Type 16 DNA in Consecutive Genital Samples Does Not Always Represent Persistent Infection as Determined by Molecular Variant Analysis

F. Coutlée, C. Hankins, N. Lapointe, 2000, Journal of Clinical Microbiology.

Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families

Y. Tabach, A. Mes-Masson, W. Foulkes, 2021, NPJ breast cancer.

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing

S. Leung, E. Goode, C. Le Page, 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer

W. Foulkes, D. Provencher, P. Tonin, 2021, Scientific Reports.

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome

C. Greenwood, A. Mes-Masson, J. Madore, 2012, PloS one.

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls

A. Mes-Masson, W. Foulkes, N. Hamel, 2020, Scientific Reports.

Cellular senescence is a central response to cytotoxic chemotherapy in high-grade serous ovarian cancer

A. Mes-Masson, D. Provencher, F. Rodier, 2018, bioRxiv.

Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity

A. Mes-Masson, D. Provencher, P. Tonin, 2012, Oncogenesis.

Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer

Anne-Marie Mes-Masson, Liliane Meunier, A. Mes-Masson, 2012, BMC Cancer.

Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease

A. Mes-Masson, D. Provencher, E. Carmona, 2020, Cancers.

VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer

A. Mes-Masson, D. Provencher, P. Tonin, 2013, Molecular oncology.

An Important Proportion of Genital Samples Submitted for Chlamydia trachomatis Detection by PCR Contain Small Amounts of Cellular DNA as Measured by β-Globin Gene Amplification

F. Coutlée, J. Vincelette, L. Labrecque, 2000, Journal of Clinical Microbiology.

DNA Damage Signaling and Apoptosis in Preinvasive Tubal Lesions of Ovarian Carcinoma

D. Provencher, V. Barrès, V. Ouellet, 2014, International Journal of Gynecologic Cancer.

Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018.

Rebecca O Barnes, A. Mes-Masson, Peter H. Watson, 2019, Biopreservation and Biobanking.

A senescence-like state is beneficial for ovarian cancer treatment

A. Mes-Masson, D. Provencher, E. Carmona, 2023, bioRxiv.